Pulse Biosciences
NASDAQ: PLSEBurlingame, US · Founded 2014 · Delaware corporation
Founders & leadership
BB
Brian B. DowExecutive
DR
Darrin R. UeckerExecutive
AW
Amy WangExecutive
Board
MZ
Maky ZanganehBoard director
CM
Christopher MarlettBoard director
ME
Mitchell E. LevinsonBoard director
RM
Robert M. LevandeBoard director
TB
Thierry B. ThaureBoard director
RJ
Robert J. GreenbergBoard director
Reported raises · per SEC filings
Form D private placements$93M disclosed across 4 rounds · 2014–2021
▶$50MraisedJul 2021 · 1 investors · Other Health CareRule 506(b)
▶$50MraisedJul 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard van den BroekDirector
- Kenneth ClarkDirector
- Sandra GardinerExecutive Officer
- Robert DugganDirector
- Edward EbbersExecutive Officer
- Mitchell LevinsonDirector
- Manmeet SoniDirector
- Darrin UeckerExecutive Officer, Director
- Mahkam ZanganehDirector
- Offering amount
- $50M
- Amount sold
- $50M
- Minimum investment
- $50M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedSep 2017 · 1 investors · BiotechnologyRule 506(b)
▶$30MraisedSep 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mitchell E. LevinsonDirector
- Thierry B. ThaureDirector
- Brian B. DowExecutive Officer
- Darrin UeckerExecutive Officer, Director
- Robert J. GreenbergDirector
- Maky ZanganehDirector
- Robert LevandeDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Sep 2017
- Incorporated
- Corporation, Nevada, 2014
- Federal exemptions
- 06b
▶$5MraisedFeb 2017 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedFeb 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mitchell E. LevinsonDirector
- Brian B. DowExecutive Officer
- Maky ZanganehDirector
- Robert M. LevandeDirector, Promoter
- Darrin R. UeckerExecutive Officer, Director
- Thierry B. ThaureDirector
- Robert J. GreenbergDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Feb 2017
- Incorporated
- Corporation, Nevada, 2014
- Federal exemptions
- 06b
▶$8MraisedNov 2014 · 72 investors · BiotechnologyRule 506(b)
▶$8MraisedNov 2014 · 72 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amy WangExecutive Officer, Director
- Robert LevandeExecutive Officer, Director
- Christopher MarlettDirector
- Offering amount
- $8M
- Amount sold
- $8M
- Sales commissions
- $800K
- Placement agents
- MDB Capital Group, LLC
- First sale
- Nov 2014
- Incorporated
- Corporation, Nevada, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Pulse Biosciences raised?
- Pulse Biosciences has disclosed $93M raised across 4 rounds.
- Where is Pulse Biosciences headquartered?
- Pulse Biosciences is headquartered in Burlingame, US.